Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab (Q21146701)

17 August 2022

Orhan Aktas

Orhan

Aktas

1 reference

17 August 2022

Sven Jarius

Sven

Jarius

1 reference

17 August 2022

Norbert Goebels

Norbert

Goebels

1 reference

17 August 2022

Marius

Ringelstein

Marius Ringelstein

1 reference

17 August 2022

Jens Harmel

Jens

Harmel

1 reference

17 August 2022

Jens Ingwersen

series ordinal

author given names

Jens

author last names

Ingwersen

1 reference

17 August 2022

Christian Mathys

series ordinal

author given names

Christian

author last names

Mathys

1 reference

Creative Commons Attribution 4.0 International

17 August 2022

language of work or name

English

0 references

publication date

2014

0 references

0 references

0 references

0 references

247

0 references

start time

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

The history of neuromyelitis optica

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Interferon alpha association with neuromyelitis optica

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Epidemiology of neuromyelitis optica in the United States: a multicenter analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

The spectrum of neuromyelitis optica

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Brain abnormalities in neuromyelitis optica

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

The role of MRI in the diagnosis of multiple sclerosis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4301061

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

27 September 2017

1 reference

https://api.crossref.org/works/10.1186%2FS12883-014-0247-3

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12883-014-0247-3

Neuromyelitis optica-like pathology is dependent on type I interferon response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12883-014-0247-3

Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12883-014-0247-3

Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12883-014-0247-3

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12883-014-0247-3

Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25516429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25516429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25516429

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12883-014-0247-3

1 reference

release_jkpwsflobneijfr4eapzv26fku

0 references

Fatcat ID

0 references

1 reference

1 reference

PubMed publication ID

25516429

1 reference